FOMAT

aFOMAT Medical Research Launches Phase 1 Services

FOMAT Unveils Pioneering Phase 1 Capabilities: Championing Diversity in Clinical Trials and Enhancing Patient Care

Oxnard, CA- FOMAT Medical Research announced today the launch of its new Phase I capabilities. The expansion will enhance FOMAT’s ability to provide efficient and high-quality services to its clients in the pharmaceutical and biotech industries. The expanded capabilities will include…

Read More
1528256066232

Simon Corman Joins FOMAT to Help Innovate Healthcare Through Diversity

Simon Corman has over 20 years of experience as a cutting-edge leader in clinical research. His strengths revolve around corporate and business development- with an ability to create strategic partnerships with various CROs and Sponsors and form public-private partnerships that support…

Read More
Fomat Research Ambulance for Clinical Trials

Innovating Our Services Alongside Our Ambulance of Research!

FOMAT is committed to providing high-quality services. We also aim to bring diversity and innovative healthcare to underrepresented populations in our community. That is why we present to you our company’s new ambulance! With our ambulance, we plan on engaging in…

Read More
Volunteer

Why Volunteer in Clinical Trials?

Why volunteer in clinical trials? Here’s a summary of the reasons why clinical trials are important Clinical trials are research studies that use human participants to help evaluate new medical treatments, drugs, or devices. They are an essential tool that helps…

Read More
oxnard chamber of commerce

FOMAT Medical Research Awarded as “Innovative Company of the Year”

  The Oxnard Chamber of Commerce has awarded FOMAT as the Innovative Company of the Year.   Oxnard, California, October 5th, 2020 FOMAT Medical Research, is a company focused on the pharmaceutical industry, based in Oxnard, California, and has over 10…

Read More
FDA

FDA Action Alert: Viela, Merck, Epizyme, Evoke and Regeneron

The next two weeks are busy ones for the U.S. Food and Drug Administration (FDA). Here’s a look at PDUFA dates for this period. Viela Bio’s Inebilizumab for NMOSD Gaithersburg, Maryland-based Viela Bio has a target action date of June 11 for its Biologics License…

Read More
Febo partnership

FOMAT Medical Research announces a partnership with Febo

Febo is a digital upstart, with its sights set on empowering patients by transforming the way they educate themselves. Febo is an online platform where you can get personalized information about your medical interests and stay updated on the newest developments,…

Read More
FOMAT SCRS19 conference

FOMAT Makes Waves at SCRS 19 

Last weekend several prominent members of the clinical research industry gathered at the 2019 Global Site Solutions Summit hosted at the Diplomat Beach Resort in Hollywood Florida. This marks the 14th year in a row that the event has been held, and…

Read More
cancer cell therapy

A ‘One-Two Punch’ to Wipe Out Cancerous Ovarian Cells

Researchers from the University of Montreal Hospital Research Centre (CRCHUM) have developed a two-step combination therapy to destroy cancer cells. In a study published in the journal Nature Communications, they show the superior therapeutic effectiveness of the “one-two punch” on cells…

Read More